Status:
COMPLETED
Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Qatar National Research Fund
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study pa...
Eligibility Criteria
Inclusion
- Patients undergoing revascularization by percutaneous intervention (PCI) for Acute Coronary Syndrome (ACS) at Mayo (STEMI and NonSTEMI patients)
- Age greater than 18
Exclusion
- Patients likely not to complete the study due to co-morbid conditions (end stage renal disease; liver failure; malignancies)
- Inability to sign a consent form or availability for follow up
- Patients unable to tolerate the blood pressure cuff inflation on both arms
- patients with tremors
- sustained non-sinus cardiac arrhythmias
- acrylic finger nails
- permanent pacemaker
- color blindness
- use of alpha blockers and short acting nitrates \< 3 hours before study
- Federal Medical Center inmates
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT01500902
Start Date
September 1 2011
End Date
April 1 2015
Last Update
September 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905